This model provides detailed sales and volume forecast data for the inflammatory bowel disease market. Including Crohn's disease and ulcerative colitis market sizing, within the context of total brand sales across the seven major markets.
Reasons to Purchase
*Quantify the current size of IBD sales in the seven major markets and understand trends in the rest of the world
*Understand IBD market trends and assess the impact of events, such as biosimilars entry, on sales of over 30 key brand name products
*Access a case study assessing the likelihood of ulcerative colitis approval for Humira and Simponi with three alternative scenario forecasts
Benchmark Genzyme's performance against key rivals in the prescription pharmaceutical sector See how the company's core products of Cerezyme, Fabrazyme and Myozyme/Lumizyme will continue to act as the primary sales growth drivers Assess the impact of the recent contamination of the Allston manufacturing facility on the company's performance through 2009
Aarkstore Enterprise specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers. We are built on the premise that reading is valuable, capable of stirring emotions and firing the imagination. Whether youre looking for new product trends or competitive analysis of a new or existing market, Aarkstore Enterprise has the best resource offerings and the expertise to make sure you get the right product every time.
